Research and Markets: PharmaPoint: Atopic Dermatitis - UK Drug Forecast and Market Analysis to 2022 Report
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mw89ch/pharmapoint) has announced the addition of the "PharmaPoint: Atopic Dermatitis - UK Drug Forecast and Market Analysis to 2022" report to their offering.
“PharmaPoint: Atopic Dermatitis - UK Drug Forecast and Market Analysis to 2022”
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit.
By the mid-to-late term of Our 2012 to 2022 forecast, Sanofi/Regeneron's dupilumab is expected to reshape the moderate and severe treatment landscape.
Other events that are expected to invoke change to the previously stagnant atopic dermatitis market include the launch of a non-steroidal topical from Anacor, AN2728, generic erosion of branded topicals Protopic and Elidel in the US, and the increasing use of pharmacological treatments in the growing markets of India and China.
The UK atopic dermatitis market is estimated to have reached $163.0m in 2012 and contributes approximately 13.1% of the total 5EU atopic dermatitis market value. This will primarily be due to strong uptake of systemic vitamin derivatives, but also the increasing uptake of systemic agents, namely methotrexate, antibiotics and corticosteroids.
- Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the UK from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the UK Atopic Dermatitis market.
Key Topics Covered:
List of Tables
List of Figures
Opportunity and Unmet Need
For more information visit http://www.researchandmarkets.com/research/mw89ch/pharmapoint
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.